Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Interim Management Statement

17 Oct 2008 14:14

RNS Number : 1250G
Aberdeen Growth Opps VCT PLC
17 October 2008
 



Aberdeen Growth Opportunities VCT PLC 

Interim Management Statement 

1. Net Asset Value

Ordinary share net asset value (NAV) of 90.65p at 31 August 2008 (97.8p at 31 May 2008)

C Ordinary share net asset value (NAV) of 97.6p at 31 August 2008 (99.2p at 31 May 2008)

The NAVs shown above are unaudited and reflect the closing bid prices of quoted securities at 31 August 2008. Unlisted companies are normally valued on a six-monthly basis and the NAVs include the Directors' valuations of unlisted investments as at 31 May 2008 adjusted for material developments within the portfolios since that date.  

2. Investments and disposals

For the Ordinary share portfolio, during the quarter ended 31 August 2008, investments totalling £498,000 were made in six unlisted or AIM/PLUS quoted companies. During the same period, a combination of partial and complete disposals of five unlisted or AIM quoted investments generated aggregate proceeds of £486,400 against cost of £309,138.

For the C share portfolio, during the quarter ended 31 August 2008, investments totalling £698,000 were made in four unlisted or AIM/PLUS quoted companies. During the same period, a combination of partial and complete disposals of four unlisted or AIM quoted investments generated aggregate proceeds of £620,246 against cost of £380,289.

There were no other material transactions during the period under review. 

3. Recent developments 

No further investments have been made since 31 August 2008.

Since that date, a partial disposal of one investment from the Ordinary share portfolio generated proceeds of £1,516,000 against cost of £884,000 and a partial disposal of one investment from the C share portfolio, generated proceeds of £2,329,000 against cost of £1,359,000.

Being invested mainly in unlisted companies, the portfolio is to some degree protected from the current volatility of stock markets. However, the recent, dramatic fall in the value of stocks quoted on AIM has reduced the NAV of the Ordinary Shares by 8p and that of the C Shares by 5p as at close of business on 16 October. The Board is not aware of any other events or transactions that have taken place between 31 August 2008 and the date of publication of this statement that have had a material impact on the financial position of the Company.

Issued on behalf of the Board

Aberdeen Asset Management PLC, Secretary

17 October 2008

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUGUGUUPRGWM
Date   Source Headline
25th Aug 20239:38 amRNSIssue of Equity
21st Aug 20233:28 pmRNSStatement re Dividend Investment Scheme
21st Jul 202312:52 pmRNSHalf-year Report
13th Jul 20234:04 pmRNSTransaction in Own Shares
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
30th Jun 20234:22 pmRNSNet Asset Value and Interim Dividend
2nd Jun 20239:41 amRNSIssue of Equity
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
24th Apr 202312:51 pmRNSResult of AGM
19th Apr 20234:49 pmRNSTransaction in Own Shares
19th Apr 20231:05 pmRNSNet Asset Value - Dividend Investment Scheme
5th Apr 202312:29 pmRNSIssue of Equity
4th Apr 202311:43 amRNSNet Asset Value(s)
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
14th Mar 20234:31 pmRNSAnnual Financial Report
3rd Mar 20239:53 amRNSIssue of Equity
21st Feb 20234:41 pmRNSTransaction in Own Shares
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202311:06 amRNSDirector/PDMR Shareholding - Replacement
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:08 amRNSDirector/PDMR Shareholding
8th Feb 20239:43 amRNSIssue of Equity
1st Feb 20233:23 pmRNSUnaudited NAV and Proposed Final Dividend
12th Dec 20223:41 pmRNSDirectorate Change
12th Dec 20223:34 pmRNSStatement re Director's Other Quoted Directorships
9th Nov 20223:00 pmRNSResult of General Meeting
4th Nov 20222:35 pmRNSTransaction in Own Shares
31st Oct 20223:54 pmRNSTransaction in Own Shares
21st Oct 20222:45 pmRNSNet Asset Value(s)
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
26th Aug 202210:04 amRNSIssue of Equity
22nd Aug 20229:33 amRNSStatement re Dividend Investment Scheme
29th Jul 202211:25 amRNSHalf-year Report
21st Jul 20224:38 pmRNSTransaction in Own Shares
13th Jul 202211:19 amRNSNet Asset Value and Interim Dividend
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
6th Jun 20222:15 pmRNSIssue of Equity
26th May 20225:02 pmRNSTransaction in Own Shares
26th Apr 202212:34 pmRNSIssue of Supplementary Prospectus
26th Apr 202210:51 amRNSIssue of Equity - Dividend Investment Scheme
21st Apr 20222:39 pmRNSStatement re Dividend Investment Scheme
6th Apr 20224:02 pmRNSNet Asset Value(s)
6th Apr 20221:45 pmRNSResult of AGM
5th Apr 20226:30 pmRNSIssue of Equity
23rd Mar 20225:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20225:05 pmRNSIssue of Equity
21st Mar 20222:59 pmRNSPublication of Suppl.Prospcts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.